{"id":2382,"date":"2020-09-23T19:33:00","date_gmt":"2020-09-23T16:33:00","guid":{"rendered":"https:\/\/teknologiateollisuus.fi\/healthtech\/?p=2382"},"modified":"2025-01-03T12:25:10","modified_gmt":"2025-01-03T10:25:10","slug":"current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use","status":"publish","type":"post","link":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/","title":{"rendered":"Current issues in Healthtech Finland&#8217;s Regulatory Affairs groups: AI, Brexit and US emergency use"},"content":{"rendered":"\n<p>Regulation serves as a gateway to the healthtech market, both in Finland and elsewhere in Europe and in third countries outside of the EU. The selected market area has direct effects on regulatory strategies and the depth and extent of product development. The September agendas of the Regulatory Affairs groups of Healthtech Finland have now been published!<\/p>\n\n\n\n<p><strong>RA1\/software&nbsp;and&nbsp;data:&nbsp;29 Sept 2020,&nbsp;10am&nbsp;\u201312.30pm<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Case:&nbsp;<a href=\"https:\/\/topdatascience.com\/\">Top&nbsp;Data&nbsp;Science<\/a>&nbsp;and examples&nbsp;of&nbsp;AI&nbsp;solutions&nbsp;in&nbsp;the&nbsp;healthtech field<\/li>\n\n\n\n<li>Analysis by Cocir of&nbsp;artificial&nbsp;intelligence&nbsp;and&nbsp;its&nbsp;relationship&nbsp;with&nbsp;MD\/IVD&nbsp;regulation<\/li>\n\n\n\n<li>Opinion&nbsp;of&nbsp;MedTech&nbsp;Europe&nbsp;on&nbsp;AI&nbsp;regulation<\/li>\n\n\n\n<li>Schrems judgement&nbsp;and&nbsp;data&nbsp;transfers of personal data to&nbsp;third&nbsp;countries<\/li>\n\n\n\n<li>Introduction to the&nbsp;QAiRA&nbsp;toolkit&nbsp;<\/li>\n<\/ul>\n\n\n\n<p><strong>RA2\/MDR:&nbsp;29 Sept 2020,&nbsp;13.30pm \u201316.30pm<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Brexit&nbsp;impacts&nbsp;on&nbsp;the&nbsp;export&nbsp;and&nbsp;registration&nbsp;of&nbsp;medical&nbsp;devices&nbsp;in&nbsp;the&nbsp;United&nbsp;Kingdom&nbsp;and&nbsp;the&nbsp;UK&nbsp;Government&nbsp;Communication&nbsp;on&nbsp;\u201cHard&nbsp;Brexit\u201d<\/li>\n\n\n\n<li>Brexit&nbsp;concerns&nbsp;expressed&nbsp;by healthtech companies&nbsp;in&nbsp;Finland<\/li>\n\n\n\n<li>US&nbsp;emergency&nbsp;use<\/li>\n\n\n\n<li>Introduction to the QAiRA toolkit<\/li>\n\n\n\n<li>Current:&nbsp;notified&nbsp;bodies&nbsp;and&nbsp;materials&nbsp;published&nbsp;by&nbsp;the&nbsp;Commission<\/li>\n\n\n\n<li>Business&nbsp;presentations:&nbsp;<a href=\"https:\/\/www.innokasmedical.fi\/\">Innokas&nbsp;Medical<\/a>&nbsp;and&nbsp;<a href=\"https:\/\/www.clinipower.fi\/\">Clinipower<\/a><\/li>\n<\/ul>\n\n\n\n<p>The&nbsp;working&nbsp;groups&nbsp;are&nbsp;free&nbsp;of&nbsp;charge&nbsp;and&nbsp;open&nbsp;to&nbsp;all&nbsp;member&nbsp;companies of Healthtech Finland&nbsp;as&nbsp;well&nbsp;as&nbsp;their&nbsp;personnel.&nbsp;<\/p>\n\n\n\n<p>Interested in participating or&nbsp;suggesting a current&nbsp;topic?&nbsp;Contact:<\/p>\n\n\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regulation serves as a gateway to the healthtech market, both in Finland and elsewhere in Europe and in third countries outside of the EU. The selected market area has direct effects on regulatory strategies and the depth and extent of product development. The September agendas of the Regulatory Affairs groups of Healthtech Finland have now [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":236,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"1093,2127,1400,856,1227,1457","_relevanssi_noindex_reason":"","inline_featured_image":false,"footnotes":""},"categories":[72],"tags":[],"em_industry":[],"em_theme":[],"class_list":["post-2382","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Current issues in Healthtech Finland&#039;s Regulatory Affairs groups: AI, Brexit and US emergency use - Terveysteknologia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/\" \/>\n<meta property=\"og:locale\" content=\"fi_FI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Current issues in Healthtech Finland&#039;s Regulatory Affairs groups: AI, Brexit and US emergency use\" \/>\n<meta property=\"og:description\" content=\"Regulation serves as a gateway to the healthtech market, both in Finland and elsewhere in Europe and in third countries outside of the EU. The selected market area has direct effects on regulatory strategies and the depth and extent of product development. The September agendas of the Regulatory Affairs groups of Healthtech Finland have now [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/\" \/>\n<meta property=\"og:site_name\" content=\"Terveysteknologia\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-23T16:33:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-03T10:25:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/06\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2100\" \/>\n\t<meta property=\"og:image:height\" content=\"1400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"P\u00e4ivi Ahlgren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Kirjoittanut\" \/>\n\t<meta name=\"twitter:data1\" content=\"P\u00e4ivi Ahlgren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Arvioitu lukuaika\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuuttia\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/\"},\"author\":{\"name\":\"P\u00e4ivi Ahlgren\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#\\\/schema\\\/person\\\/964d40eb9a84d0edfc1989b7784ea950\"},\"headline\":\"Current issues in Healthtech Finland&#8217;s Regulatory Affairs groups: AI, Brexit and US emergency use\",\"datePublished\":\"2020-09-23T16:33:00+00:00\",\"dateModified\":\"2025-01-03T10:25:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2024\\\/06\\\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg\",\"articleSection\":[\"News\"],\"inLanguage\":\"fi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/\",\"url\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/\",\"name\":\"Current issues in Healthtech Finland's Regulatory Affairs groups: AI, Brexit and US emergency use - Terveysteknologia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2024\\\/06\\\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg\",\"datePublished\":\"2020-09-23T16:33:00+00:00\",\"dateModified\":\"2025-01-03T10:25:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#\\\/schema\\\/person\\\/964d40eb9a84d0edfc1989b7784ea950\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/#breadcrumb\"},\"inLanguage\":\"fi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fi\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/#primaryimage\",\"url\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2024\\\/06\\\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg\",\"contentUrl\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2024\\\/06\\\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg\",\"width\":2100,\"height\":1400,\"caption\":\"Kuvituskuva henkil\u00f6t tietokoneet neuvotteluhuone\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/en\\\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Etusivu\",\"item\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ajankohtaista\",\"item\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/ajankohtaista\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/ajankohtaista\\\/?categories=72\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Current issues in Healthtech Finland&#8217;s Regulatory Affairs groups: AI, Brexit and US emergency use\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#website\",\"url\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/\",\"name\":\"Terveysteknologia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fi\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#\\\/schema\\\/person\\\/964d40eb9a84d0edfc1989b7784ea950\",\"name\":\"P\u00e4ivi Ahlgren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fi\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g\",\"caption\":\"P\u00e4ivi Ahlgren\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Current issues in Healthtech Finland's Regulatory Affairs groups: AI, Brexit and US emergency use - Terveysteknologia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/","og_locale":"fi_FI","og_type":"article","og_title":"Current issues in Healthtech Finland's Regulatory Affairs groups: AI, Brexit and US emergency use","og_description":"Regulation serves as a gateway to the healthtech market, both in Finland and elsewhere in Europe and in third countries outside of the EU. The selected market area has direct effects on regulatory strategies and the depth and extent of product development. The September agendas of the Regulatory Affairs groups of Healthtech Finland have now [&hellip;]","og_url":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/","og_site_name":"Terveysteknologia","article_published_time":"2020-09-23T16:33:00+00:00","article_modified_time":"2025-01-03T10:25:10+00:00","og_image":[{"width":2100,"height":1400,"url":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/06\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg","type":"image\/jpeg"}],"author":"P\u00e4ivi Ahlgren","twitter_card":"summary_large_image","twitter_misc":{"Kirjoittanut":"P\u00e4ivi Ahlgren","Arvioitu lukuaika":"2 minuuttia"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/#article","isPartOf":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/"},"author":{"name":"P\u00e4ivi Ahlgren","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#\/schema\/person\/964d40eb9a84d0edfc1989b7784ea950"},"headline":"Current issues in Healthtech Finland&#8217;s Regulatory Affairs groups: AI, Brexit and US emergency use","datePublished":"2020-09-23T16:33:00+00:00","dateModified":"2025-01-03T10:25:10+00:00","mainEntityOfPage":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/"},"wordCount":317,"image":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/#primaryimage"},"thumbnailUrl":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/06\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg","articleSection":["News"],"inLanguage":"fi"},{"@type":"WebPage","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/","url":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/","name":"Current issues in Healthtech Finland's Regulatory Affairs groups: AI, Brexit and US emergency use - Terveysteknologia","isPartOf":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#website"},"primaryImageOfPage":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/#primaryimage"},"image":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/#primaryimage"},"thumbnailUrl":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/06\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg","datePublished":"2020-09-23T16:33:00+00:00","dateModified":"2025-01-03T10:25:10+00:00","author":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#\/schema\/person\/964d40eb9a84d0edfc1989b7784ea950"},"breadcrumb":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/#breadcrumb"},"inLanguage":"fi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/"]}]},{"@type":"ImageObject","inLanguage":"fi","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/#primaryimage","url":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/06\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg","contentUrl":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/06\/Kuvituskuva-henkilot-tietokoneet-neuvotteluhuone.jpeg","width":2100,"height":1400,"caption":"Kuvituskuva henkil\u00f6t tietokoneet neuvotteluhuone"},{"@type":"BreadcrumbList","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/en\/current-issues-in-healthtech-finlands-regulatory-affairs-groups-ai-brexit-and-us-emergency-use\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Etusivu","item":"https:\/\/teknologiateollisuus.fi\/healthtech\/"},{"@type":"ListItem","position":2,"name":"Ajankohtaista","item":"https:\/\/teknologiateollisuus.fi\/healthtech\/ajankohtaista\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/teknologiateollisuus.fi\/healthtech\/ajankohtaista\/?categories=72"},{"@type":"ListItem","position":4,"name":"Current issues in Healthtech Finland&#8217;s Regulatory Affairs groups: AI, Brexit and US emergency use"}]},{"@type":"WebSite","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#website","url":"https:\/\/teknologiateollisuus.fi\/healthtech\/","name":"Terveysteknologia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/teknologiateollisuus.fi\/healthtech\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fi"},{"@type":"Person","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#\/schema\/person\/964d40eb9a84d0edfc1989b7784ea950","name":"P\u00e4ivi Ahlgren","image":{"@type":"ImageObject","inLanguage":"fi","@id":"https:\/\/secure.gravatar.com\/avatar\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g","caption":"P\u00e4ivi Ahlgren"}}]}},"lang":"en","translations":{"en":2382},"pll_sync_post":{},"_links":{"self":[{"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/posts\/2382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/comments?post=2382"}],"version-history":[{"count":2,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/posts\/2382\/revisions"}],"predecessor-version":[{"id":3945,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/posts\/2382\/revisions\/3945"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/media\/236"}],"wp:attachment":[{"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/media?parent=2382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/categories?post=2382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/tags?post=2382"},{"taxonomy":"em_industry","embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/em_industry?post=2382"},{"taxonomy":"em_theme","embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/em_theme?post=2382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}